NITI Aayog has identified critical inefficiencies in India’s research sector, noting that R&D spending remains low at 0.65% of GDP. The report calls for reducing administrative delays and boosting private sector involvement. This matters to investors because a more efficient research ecosystem is vital for the long-term innovation and global competitiveness of Indian industries like pharmaceuticals and technology.
A new report from NITI Aayog has put a spotlight on the structural challenges holding back research and development (R&D) in India. Titled "Ease of Doing Research & Development in India," the document provides a candid look at why the country has struggled to boost its innovation output. While global leaders in research allocate a much higher share of their economy to R&D—such as 3.5% of GDP in the United States or 4.5% in South Korea—India’s spending has remained stagnant at roughly 0.65% of GDP for years.
The report identifies that money is not just tight; it is also unevenly distributed. A significant issue raised is the concentration of resources, where approximately 80% of funding from the Anusandhan National Research Foundation (ANRF) is directed toward the Indian Institutes of Technology (IITs). This leaves many other state universities and research centres to struggle with outdated laboratories, broken equipment, and a lack of basic facilities, creating a two-tier system where only elite institutions thrive.
Beyond the funding figures, the report flags deep-seated procedural issues that discourage scientific work. Researchers frequently report that getting approved funds is a long, difficult process, with many facing delays of three to six months. Cumbersome procurement rules and a lack of clear communication between funding agencies and scientists often stop projects from moving forward at the right pace. The report notes that this has created a "trust deficit" that effectively stifles the progress of critical scientific inquiries.
To address these problems, NITI Aayog has proposed a "Unified Architecture for Project Management System." The goal of this platform is to track grants from the initial approval stage to the final outcome using a permanent identification number. By making the selection process more transparent and removing the ambiguity around grant approvals, the government aims to stop the duplication of funding and ensure that money goes to projects with the most merit.
For the Indian stock market and business landscape, this report is important because scientific innovation is the backbone of long-term growth in sectors like pharmaceuticals, chemicals, renewable energy, and information technology. Currently, public institutions account for about 64% of total R&D expenditure in India, which shows a heavy reliance on government support rather than private-sector collaboration. If these proposed reforms can successfully reduce administrative bottlenecks and encourage more private industry involvement, it could help companies in these sectors commercialize new technologies faster and remain competitive in global markets. The key monitorable for investors will be whether the government adopts these structural changes and if they lead to faster, more transparent access to research capital for the broader scientific community.